TURINABOL 20 mg 50 Tabs Nakon Medical USA

$75.00

Product Short Description

TURINABOL 20 mg 50 Tabs Nakon Medical USA deliversΒ chlorodehydromethyltestosteroneΒ (C21H28ClO2), the 4-chloro-17Ξ±-methyl-Δ¹-testosterone derivative exhibiting lean anabolic response (~180:50 ratio) with minimal aromatization, at 20 mg strength characteristic of East German Tbol formulations. Domestic U.S. production eliminates customs exposure servingΒ DEA Schedule IIIΒ compliant institutional channels through verified performance networks.​

Category:
Description

Product Overview

Nakon Medical USA’s Turinabol 20 mg presentsΒ CDMT, featuring 4-chloro substitution and C1,2 unsaturation conferring non-aromatizing anabolic activity with 17Ξ±-methylation enabling oral bioavailability (~16 hour half-life), in small round scored tablets replicating historical Oral-Turinabol morphology for institutional catalog integration across DEA-registered platforms. The 50-tablet HDPE bottle supportsΒ CIII-compliant inventory reconciliationΒ under 21 CFR 1304.22 requiring Schedule III accountability for institutional handlers.​

U.S.-domiciled GMP manufacturingΒ maintains molecular specifications (MW 360.91) distinguishing legitimate pedigree from underground conversions showing potency variance. This presentation serves buyers requiringΒ Form 222 documentationΒ across U.S. jurisdictions, avoiding grey-market risks.​

Nakon positions withinΒ verified DEA Schedule III ecosystemsΒ for licensed clientele underΒ 21 CFR 1301.13, excluding therapeutic claims.

Brand & Manufacturer Information

Nakon Medical USAΒ manufactures Schedule III substances through domestic GMP facilities serving institutional networks withΒ DEA verification. Turinabol 20 mg fits Nakon’s non-aromatizing oral catalog authenticating legitimacy versus powder alternatives rejected by handlers.

Domestic warehousing supportsΒ Form 222 platformsΒ with serialized lots verifying 20 mg potency via HPLC, essential for procurement.​

Active Compound Information

ContainsΒ chlorodehydromethyltestosteroneΒ (4-chloro-17Ξ±-methyl-Δ¹-testosterone), exhibitingΒ 4-chloro modificationΒ preventing aromatization while maintaining anabolic potency characteristic of 17Ξ±-methyl steroids.Β DEA Schedule IIIΒ reflects hepatotoxicity and virilization potential;Β WADA S1.1a prohibitedΒ with long-term metabolites detectable months post-administration.​

20 mg strength matches historical GDR dosing; formula C21H28ClO2.​

Product Specifications

Specification Details
Product Name TURINABOL 20 mg 50 Tabs Nakon Medical USA
Active Compound Chlorodehydromethyltestosterone (C21H28ClO2) ​
Strength 20 mg per round scored tablet ​
Quantity 50 tablets per HDPE bottle
Form Oral scored tablets
Category DEA Schedule III controlled substance
Appearance White, round, single-scored
Molecular Weight 360.91 g/mol
Half-Life ~16 hours ​
Label Elements “20 mg”, CIII warnings, lot code

Quality Control & Testing Standards

20 mg CDMTΒ requiresΒ USP <621> HPLC assayΒ (90-110%),Β USP <711> dissolution, andΒ chloro-substitution verification. Nakon verifiesΒ C21H28ClO2 identityΒ distinguishing GMP from underground sources.​

CIII packagingΒ meets USP <671> withΒ ICH Q1A(R2)Β stability for extended shelf-life.

Intended Use & Market Positioning

TargetsΒ DEA-registered CIII institutional researchersΒ via encrypted fulfillment withΒ Form 222 accountability.

No protocols or outcomes representedΒ in CIII positioning.

CDMT is DEA Schedule IIIΒ underΒ 21 USC Β§812; non-medical handling violates CSA (5 years/$250,000 penalties).Β Buyers assume DEA liability;Β no claims provided.​

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “TURINABOL 20 mg 50 Tabs Nakon Medical USA”
Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.